Paperwork, Paradox, and PRN: Psychotropic Medication Deficiencies in Assisted Living
暂无分享,去创建一个
[1] Nancy B. Lerner,et al. Deficiency Citations on Inappropriate Psychotropics Use Related to Care for Behavioral Symptoms of Dementia. , 2022, Journal of the American Medical Directors Association.
[2] Christopher J. Wretman,et al. Pro Re Nata Prescribing and Administration of Psychotropic Medications in Assisted Living: A 7-State Study. , 2021, Journal of the American Medical Directors Association.
[3] Christopher J. Wretman,et al. Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families , 2021, Journal of applied gerontology : the official journal of the Southern Gerontological Society.
[4] R. Clifford,et al. Exploring stakeholder roles in medication management for people living with dementia. , 2021, Research in social & administrative pharmacy : RSAP.
[5] David R. Johnson,et al. Maximizing Well-Being in the Context of Long-Term Services and Supports: A Q Methodological Approach , 2021, Clinical gerontologist.
[6] J. Brazier,et al. Connecting policy to licensed assisted living communities, introducing health services regulatory analysis. , 2021, Health services research.
[7] Christopher J. Wretman,et al. To What Extent Do Local Nursing Home Prescribing Patterns Relate to Psychotropic Prescribing in Assisted Living? , 2020, Journal of the American Medical Directors Association.
[8] Ann Christine Frankowski,et al. "It's a lot!" the universal worker model and dementia care in assisted living. , 2020, Geriatric nursing.
[9] B. Resnick,et al. A Description of Staff-resident Interactions in Assisted Living , 2020, Clinical nursing research.
[10] H. Young,et al. Assuring Quality in Nursing Homes: The Black Box of Administrative and Clinical Leadership --a Scoping Review. , 2020, The Gerontologist.
[11] J. Patterson,et al. CMS Mega-Rule Update and the Status of Pharmacy-Related Deficiencies in Nursing Homes , 2020, Journal of applied gerontology : the official journal of the Southern Gerontological Society.
[12] R. Werner,et al. Two Decades of Nursing Home Compare: What Have We Learned? , 2020, Medical care research and review : MCRR.
[13] Susan C. Miller,et al. Nursing Home Culture Change Practices and Survey Deficiencies: A National Longitudinal Panel Study. , 2020, The Gerontologist.
[14] R. Stewart,et al. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes , 2020, European Journal of Epidemiology.
[15] K. Hyer,et al. Using Deficiency Data to Measure Quality in Assisted Living Communities: A Florida Statewide Study , 2020, Journal of aging & social policy.
[16] Nancy B. Lerner,et al. Comparing residential long-term care regulations between nursing homes and assisted living facilities. , 2020, Nursing outlook.
[17] Candace L. Kemp,et al. A Profile of the Assisted Living Direct Care Workforce in the United States , 2020, Journal of applied gerontology : the official journal of the Southern Gerontological Society.
[18] S. Jordan,et al. PRN Medicines Management for Psychotropic Medicines in Long-Term Care Settings: A Systematic Review , 2019, Pharmacy.
[19] J. Spetz,et al. Home And Community-Based Workforce For Patients With Serious Illness Requires Support To Meet Growing Needs. , 2019, Health affairs.
[20] S. Zimmerman,et al. Staffing and Service Availability in Assisted Living: The Importance of Nurse Delegation Policies , 2018, Journal of the American Geriatrics Society.
[21] B. Golomb,et al. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action , 2018, Drugs & Aging.
[22] K. Lapane. Reducing Off‐Label Antipsychotic Use in Older Adults: Time to Look Beyond the Doors of Nursing Homes , 2018, Journal of the American Geriatrics Society.
[23] Claire Chiang,et al. Association of the Centers for Medicare & Medicaid Services’ National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014 , 2018, JAMA internal medicine.
[24] Trisha Greenhalgh,et al. Hidden Work and the Challenges of Scalability and Sustainability in Ambulatory Assisted Living , 2018, ACM Trans. Comput. Hum. Interact..
[25] Danijela Gnjidic,et al. Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis , 2017, Alzheimer's & dementia.
[26] F. Khan,et al. Association between antipsychotics and adverse outcomes in dementia , 2017 .
[27] K. Langa,et al. Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA , 2017, International journal of geriatric psychiatry.
[28] C. Parsons. Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem , 2017, Therapeutic advances in drug safety.
[29] Wendy A. Rogers,et al. Understanding Decision Making Among Direct Care Workers in Assisted Living , 2016 .
[30] P. Carder,et al. State Regulation of Medication Administration by Unlicensed Assistive Personnel in Residential Care and Adult Day Services Settings. , 2016, Research in gerontological nursing.
[31] Lauren W. Cohen,et al. Addressing Antipsychotic Use in Assisted Living Residents with Dementia , 2015, Journal of the American Geriatrics Society.
[32] Christopher S. Brunt,et al. The Effects of Antipsychotic Quality Reporting on Antipsychotic and Psychoactive Medication Use. , 2015, Health services research.
[33] C. Lyketsos,et al. Assessment and management of behavioral and psychological symptoms of dementia , 2015, BMJ : British Medical Journal.
[34] S. Zimmerman,et al. Dementia prevalence and care in assisted living. , 2014, Health affairs.
[35] H. Young,et al. Medication management roles in assisted living. , 2014, Journal of Gerontological Nursing.
[36] Nancy B. Lerner,et al. Are nursing home survey deficiencies higher in facilities with greater staff turnover. , 2014, Journal of the American Medical Directors Association.
[37] H. Young,et al. Strategies to promote safe medication administration in assisted living settings. , 2013, Research in gerontological nursing.
[38] S. Crystal,et al. Response to regulatory stringency: the case of antipsychotic medication use in nursing homes. , 2012, Health economics.
[39] L. Teri,et al. Reactions of assisted living staff to behavioral and psychological symptoms of dementia. , 2012, Geriatric nursing.
[40] P. Carder. "Learning about your residents": how assisted living residence medication aides decide to administer pro re nata medications to persons with dementia. , 2012, The Gerontologist.
[41] Lauren W. Cohen,et al. Medication Administration Errors in Assisted Living: Scope, Characteristics, and the Importance of Staff Training , 2011, Journal of the American Geriatrics Society.
[42] N. Castle,et al. What is nursing home quality and how is it measured? , 2010, The Gerontologist.
[43] M. Olfson,et al. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. , 2009, Health affairs.
[44] S. Zimmerman,et al. Understanding the intersection of individual needs and choices with organizational practices: the case of medication management in assisted living. , 2009, The Gerontologist.
[45] H. Young,et al. Types, Prevalence, and Potential Clinical Significance of Medication Administration Errors in Assisted Living , 2008, Journal of the American Geriatrics Society.
[46] J. Engberg,et al. Nursing Home Deficiency Citations for Medication Use , 2007 .
[47] J. Fereday,et al. Demonstrating Rigor Using Thematic Analysis: A Hybrid Approach of Inductive and Deductive Coding and Theme Development , 2006 .
[48] J. W. Ryan,et al. Medication administration by unlicensed caregivers. A model program. , 2003, Journal of gerontological nursing.
[49] R. Stone,et al. Improving the long-term care workforce serving older adults. , 2010, Health affairs.